126 related articles for article (PubMed ID: 37864575)
1. Cancer patients' experience of receiving variant of uncertain significance results: An Asian perspective.
Ishak ND; Shaw T; Li ST; Yuen J; Goh HX; Chua ZY; Suresh P; Que FVF; Zhang Z; Chiang J; Ngeow J
J Genet Couns; 2023 Oct; ():. PubMed ID: 37864575
[TBL] [Abstract][Full Text] [Related]
2. Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Solomon I; Harrington E; Hooker G; Erby L; Axilbund J; Hampel H; Semotiuk K; Blanco A; Klein WMP; Giardiello F; Leonard L
J Genet Couns; 2017 Aug; 26(4):866-877. PubMed ID: 28127677
[TBL] [Abstract][Full Text] [Related]
3. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
Reuter C; Chun N; Pariani M; Hanson-Kahn A
J Genet Couns; 2019 Aug; 28(4):878-886. PubMed ID: 31050105
[TBL] [Abstract][Full Text] [Related]
4. Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.
Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
Clin Genet; 2015 Dec; 88(6):523-9. PubMed ID: 25640009
[TBL] [Abstract][Full Text] [Related]
5. Cancer patients' understandings of genetic variants of uncertain significance in clinical care.
Amano Y; Raz A; Timmermans S; Shkedi-Rafid S
J Community Genet; 2022 Aug; 13(4):381-388. PubMed ID: 35616809
[TBL] [Abstract][Full Text] [Related]
6. Experiences of patients seeking to participate in variant of uncertain significance reclassification research.
Makhnoon S; Garrett LT; Burke W; Bowen DJ; Shirts BH
J Community Genet; 2019 Apr; 10(2):189-196. PubMed ID: 30027524
[TBL] [Abstract][Full Text] [Related]
7. Patients' perspectives of variants of uncertain significance and strategies for uncertainty management.
Makhnoon S; Shirts BH; Bowen DJ
J Genet Couns; 2019 Apr; 28(2):313-325. PubMed ID: 30636062
[TBL] [Abstract][Full Text] [Related]
8. A Modern Dilemma: How Experts Grapple with Ambiguous Genetic Test Results.
Scherr CL; Ross Arguedas AA; Getachew-Smith H; Marshall-Fricker C; Shrestha N; Brooks K; Fischhoff B; Vadaparampil ST
Med Decis Making; 2020 Jul; 40(5):655-668. PubMed ID: 32734842
[No Abstract] [Full Text] [Related]
9. Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics.
Menke C; Nagaraj CB; Dawson B; He H; Tawde S; Wakefield EG
J Genet Couns; 2021 Dec; 30(6):1559-1569. PubMed ID: 33969574
[TBL] [Abstract][Full Text] [Related]
10. A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study.
Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
Genet Med; 2015 Sep; 17(9):739-46. PubMed ID: 25569439
[TBL] [Abstract][Full Text] [Related]
11. Patients' reactions and follow-up testing decisions related to Tay-Sachs (HEXA) variants of uncertain significance results.
Yip T; Grinzaid KA; Bellcross C; Moore RH; Page PZ; Hardy MW
J Genet Couns; 2019 Aug; 28(4):738-749. PubMed ID: 30843643
[TBL] [Abstract][Full Text] [Related]
12. Approach to the patient with a variant of uncertain significance on genetic testing.
Newey PJ
Clin Endocrinol (Oxf); 2022 Oct; 97(4):400-408. PubMed ID: 35996232
[TBL] [Abstract][Full Text] [Related]
13. Examining the Effectiveness of Genetic Counselors' Communication of Variant of Uncertain Significance Results of Breast Cancer Genes.
Zhong L; Donovan EE; Vangelisti AL
Health Commun; 2021 May; 36(5):606-615. PubMed ID: 32122169
[TBL] [Abstract][Full Text] [Related]
14. Patient goals, motivations, and attitudes in a patient-driven variant reclassification study.
Tsai GJ; Garrett LT; Makhnoon S; Bowen DJ; Burke W; Shirts BH
J Genet Couns; 2019 Jun; 28(3):558-569. PubMed ID: 31163102
[TBL] [Abstract][Full Text] [Related]
15. Implementation matters: How patient experiences differ when genetic counseling accompanies the return of genetic variants of uncertain significance.
Patel HV; Henrikson NB; Ralston JD; Leppig K; Scrol A; Jarvik GP; DeVange S; Larson EB; Hartzler AL
AMIA Annu Symp Proc; 2021; 2021():950-958. PubMed ID: 35309003
[TBL] [Abstract][Full Text] [Related]
16. From the laboratory to the clinic: sharing BRCA VUS reclassification tools with practicing genetics professionals.
Augusto BM; Lake P; Scherr CL; Couch FJ; Lindor NM; Vadaparampil ST
J Community Genet; 2018 Jul; 9(3):209-215. PubMed ID: 29124491
[TBL] [Abstract][Full Text] [Related]
17. Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives.
Abdel-Razeq H; Tamimi F; Abujamous L; Abdel-Razeq R; Abunasser M; Edaily S; Abdulelah H; Khashabeh RA; Bater R
Front Oncol; 2022; 12():673094. PubMed ID: 35402282
[TBL] [Abstract][Full Text] [Related]
18. Assessing parental understanding of variant reclassification in pediatric neurology and developmental pediatrics clinics.
Margolin A; Helm BM; Treat K; Prucka SK; Halverson CME
J Community Genet; 2021 Oct; 12(4):663-670. PubMed ID: 34558037
[TBL] [Abstract][Full Text] [Related]
19. Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.
Petrucelli N; Lazebnik N; Huelsman KM; Lazebnik RS
Genet Test; 2002; 6(2):107-13. PubMed ID: 12215249
[TBL] [Abstract][Full Text] [Related]
20. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C
Gene; 2023 Apr; 862():147281. PubMed ID: 36775216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
